Lo Andrew 4
4 · Roivant Sciences Ltd. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-15+71,850→ 71,850 totalExercise: $3.50Exp: 2032-09-14→ Common Shares (71,850 underlying) - Award
Common Shares
2022-09-15+52,142→ 52,142 total
Footnotes (2)
- [F1]Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date.
- [F2]Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date.